Drugs / Oxatomide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00033813 | Jan 2002 → Dec 2006 | Duchenne muscular dystrophy | Cooperative International Neuromuscular Research Group | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxatomide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00033813 ↗ |
| Known as | Celtect | ChEMBL registry synonym — accepted as the source's own label CHEMBL13828 ↗ |
| Known as | Cobiona | ChEMBL registry synonym — accepted as the source's own label CHEMBL13828 ↗ |
| Known as | Dasten | ChEMBL registry synonym — accepted as the source's own label CHEMBL13828 ↗ |
| Known as | NSC-309710 | ChEMBL registry synonym — accepted as the source's own label CHEMBL13828 ↗ |
| Known as | Oxatomida | ChEMBL registry synonym — accepted as the source's own label CHEMBL13828 ↗ |
| Known as | R 35,443 | ChEMBL registry synonym — accepted as the source's own label CHEMBL13828 ↗ |
| Known as | tinset | “Oxatomide (tinset)” NCT00033813 ↗ |
| Action | Inhibit | “Histamine H1 receptor antagonist” CHEMBL13828 ↗ |
| Modality | Other / unclassified | “mast cell stabilizer Oxatomide” NCT00033813 ↗ |
| Target | HRH1 | “Histamine H1 receptor antagonist” CHEMBL13828 ↗ |